Ann: Imugene HER-Vaxx Phase 2 Clinical Update, page-5

  1. 2,930 Posts.
    lightbulb Created with Sketch. 12949
    Hi all
    Certainly good news, but this is only the entree. The independent Data Monitoring Committee is just there to say - as an independent body - that the results confirm safety and that the study should continue. The patients are "responding positively" and Leslie hints at good news, but we have to wait for them to release interim results before we can know more about that. We don't have a firm timeframe for the interim results but today's announcement makes it more likely that the news, when it comes, will be good.
    Cheers
    Dave
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
25.0¢
Change
-0.020(7.41%)
Mkt cap ! $72.12M
Open High Low Value Volume
27.0¢ 27.8¢ 24.5¢ $975.5K 3.781M

Buyers (Bids)

No. Vol. Price($)
10 137872 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 26500 3
View Market Depth
Last trade - 16.11pm 01/08/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.